Clinical trials recruiting for Colon Neoplasm
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Anti-PD-L1 Monoclonal Antibody | 1 |
| Capecitabine | 1 |
| Clostridium butyricum | 1 |
| Mesalamine | 1 |
| Oxaliplatin | 1 |
| Standard | 1 |
| Tranexamic Acid | 1 |
| encorafenib + cetuximab + FOLFIRI | 1 |
Self-screener
Recruiting trials
- Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab.
- Evaluating the Impact of Financial Navigation on Financial Catastrophe and Distress for Cancer Care
- Exploration of Circulating microRNAs as Biomarkers of Chemo-induced Peripheral Neuropathy: a Study in Cancer Patients
- Induction Chemotherapy Combined With Neoadjuvant Immunotherapy for MSS Colon Cancer
- Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection
- Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
- Tranexamic Acid During Colonic Endoscopic Resection Procedures
Related conditions
Trials recruiting for Colon Neoplasm often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Colon Neoplasm trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.